22
history of low trauma fracture at age 45 year, postmenopausal women age  50
–65  with  risk  factors  for  osteoporosis  besides  menopause, women  age  65  years  and  older  regardless  of  additional  risk  factors,
postmenopausal women who present with fractures, women considering therapy for osteoporosis if BMD testing  would facilitate such decision
and finally women who have been on HRT for prolonged periods. b.
Menopausal Women‟s Risk Factors
Risk  factors  in  menopausal  women  can  be  categorized  as modifiable and non- modifiable factors. Non-modifiable risk factors are
as  follow:  age  65  years  and  older,  female,  Caucasian  and  Asian women, early menopause before age 45, women whose ovaries  were
removed  before  menopause,  small  body  build,  family  history  of fractures,  and  experience  of  bone  fragility  fracture,  while  modifiable
risk  factors  are  as  follows:  inadequate  calcium  intake,  sedentary lifestyle,  regular  smoking,  regular  drinking  of  alcohol,  regular  and
excessive drinking of coffee, Body Mass Index BMI lower than 19kg, excess  exercise,  propensity  for  falling  due  to  impaired  vision  and
estrogen  deficiency  in  pre-menopause  due  to  taking  gonadotropin releasing hormone GnRH analogue.
7. Osteoporosis Symptoms
A  decrease  in  bone  mass  in  osteoporosis  does  not  cause  pain  or other symptoms.    Osteoporosis disease often happens to be asymptomatic
until there is a broken bone or a fracture, thus it is called a silent disease. perpustakaan.uns.ac.id
commit to user
23
Osteoporotic  fractures  cause  pain  and  disability.  In  most  cases  this  will remain  throughout  life,  but  in  other  cases  it  will  gradually  disappear  or
improve  Hurricane,  2005.  Osteoporosis  symptoms  can  be  a  pain  in  the bones, reduced height and body hunchback.
c. Pain in Bones
The  bone  pain  in  osteoporosis  can  be  acute  or  chronic.  Acute pain  comes  from  a  bone  or  periosteum  due  to  a  recent  fracture,  while
chronic  pain  comes  from  the  soft  tissue  due  to  a  ligament and  muscle deformity.
d. Reduced Height
Height  shrinkage  occurs  due  to  compression  fractures  in  the vertebrae  and  it  is  usually  accompanied  either  by  symptoms  or
asymptomatic, which lasts for several days with a severe pain to several months,  respectively.  A  reduced  height  occurs  if  there  is  fracture  in
several  places  of  the  rear  vertebrae  for  several  times  and therefore  the height will be shorter than the long span arms. In normal circumstances,
the  height  and  the  long  span  arms  both  have  the  same  size.  Long stretches  of  both  arms  are  measured  from  the  tip  of  the  right  middle
finger across the chest to the tip of the left middle finger. e.
Body Hunchback Body  hunchback  aka  kyphosis  is  the  spinal  deformities,  which
can occur as the result of compression fractures. perpustakaan.uns.ac.id
commit to user
24
8. Osteoporosis Diagnosis
There  are  mainly  two  criteria  to  diagnose  osteoporosis  either  by measurement of BMD or by biochemical markers of bone turnover.
BMD  can  be  measured  by  Dual  Energy  X-ray  Absorptiometry DXA.  WHO  diagnostic  criteria  are  used  to  diagnose  osteoporosis  in
women by comparing the measured BMD with maximum BMD in young women and considering lower value or one equal to 2.5 times of standard
deviation for diagnosis of osteoporosis. Risk of  bone fracture is increased 1.4-2.6  times  for  one  time  of  decreasing  of  standard  deviation  Grade  A,
Level Ia. As biochemical index of bone formation and resorption is changed
by several factors, it is not suggested to use  biochemical markers of bone turnover for diagnosis of osteoporosis and in addition, it may be unusual in
several diseases. However, it can be used together with BMD to assess risk of  bone  fracture.  The  index is  useful  for treatment monitoring  after  three
months and a year and to assess response to treatment with rapid detection. Biochemical  index  of  bone  resorption includes  urinary  deoxypyridinoline
DPD, urinary N-telopeptide NTx and serum C-telopeptide CTx while biochemical  index  of  bone  formation  includes  bone  specific  alkaline
phosphatase  BSAP,  osteocalcin  and  N-terminal  propeptide  of  type  1 procollagen P1NP.
commit to user
25
9. Osteoporosis Investigations